Net Income for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current net income (TTM) is $542.70M USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$542.70M
YoY change
+0.2%
5Y CAGR
+7.4%
Peak year (2021)
$661.80M
Cumulative net income
$5.17B
Net Income history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Net Income history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $493.70M | +0.2% | ||
| 2024 | $492.70M | -17.0% | ||
| 2023 | $593.40M | +1.3% | ||
| 2022 | $585.90M | -11.5% | ||
| 2021 | $661.80M | +91.2% | ||
| 2020 | $346.20M | +43.2% | ||
| 2019 | $241.70M | +16.8% | ||
| 2018 | $206.90M | +37.3% | ||
| 2017 | $150.70M | +4.9% | ||
| 2016 | $143.60M | +50.2% | ||
| 2015 | $95.60M | -24.8% | ||
| 2014 | $127.10M | +13.2% | ||
| 2013 | $112.30M | +39.2% | ||
| 2012 | $80.70M | +6.9% | ||
| 2011 | $75.50M | +15.6% | ||
| 2010 | $65.30M | -10.1% | ||
| 2009 | $72.60M | -15.6% | ||
| 2008 | $86.00M | +21.6% | ||
| 2007 | $70.70M | +5.4% | ||
| 2006 | $67.10M | +47.1% | ||
| 2005 | $45.60M | +135.1% | ||
| 2004 | $19.40M | -39.2% | ||
| 2003 | $31.90M | +73.4% | ||
| 2002 | $18.40M | -453.8% | ||
| 2001 | -$5.20M | -425.0% | ||
| 2000 | $1.60M | -95.9% | ||
| 1999 | $38.70M | +477.6% | ||
| 1998 | $6.70M | -84.9% | ||
| 1997 | $44.40M | +170.7% | ||
| 1996 | $16.40M | -42.9% | ||
| 1995 | $28.70M | +5.1% | ||
| 1994 | $27.30M | +16.2% | ||
| 1993 | $23.50M | +19.3% | ||
| 1992 | $19.70M | -331.8% | ||
| 1991 | -$8.50M | -297.7% | ||
| 1990 | $4.30M | -79.2% | ||
| 1989 | $20.70M | +19.0% | ||
| 1988 | $17.40M | +27.0% | ||
| 1987 | $13.70M | -19.4% | ||
| 1986 | $17.00M | +13.3% | ||
| 1985 | $15.00M | — |
Net Income values are taken from West Pharmaceutical Services's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of West Pharmaceutical Services (WST) net income is $493.70M – edged up 0.2% year-over-year.
Across 2020–2025 (5 years), West Pharmaceutical Services net income produced a CAGR of +7.4% – with the latest reading among the more recent periods of the dataset.
Between 2021 and 2025, West Pharmaceutical Services net income declined 25.4%, falling from $661.80M to $493.70M.
The highest annual net income of $661.80M was reported in 2021. The lowest in the available history was -$8.50M in 1991.
Within Healthcare, West Pharmaceutical Services (WST) ranks 9th among 8 peers we track. The peer median for net income is $15.15B.
West Pharmaceutical Services Net Income by Year
West Pharmaceutical Services Net Income 2025: $493.70M
West Pharmaceutical Services net income in 2025 was $493.70M, edged up 0.2% from 2024.
West Pharmaceutical Services Net Income 2024: $492.70M
West Pharmaceutical Services net income in 2024 was $492.70M, declined 17.0% below 2023.
West Pharmaceutical Services Net Income 2023: $593.40M
West Pharmaceutical Services net income in 2023 was $593.40M, edged up 1.3% from 2022.
West Pharmaceutical Services Net Income 2022: $585.90M
West Pharmaceutical Services net income in 2022 was $585.90M, declined 11.5% below 2021.
West Pharmaceutical Services Net Income 2021: $661.80M
West Pharmaceutical Services net income in 2021 was $661.80M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Net Income
Companies in the same sector as West Pharmaceutical Services, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's net income?
- Latest reported net income for West Pharmaceutical Services (WST) is $542.70M (period ending March 31, 2026).
How has West Pharmaceutical Services net income changed year-over-year?
- West Pharmaceutical Services (WST) net income changed +0.2% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services net income?
- West Pharmaceutical Services (WST) net income compound annual growth rate is +7.4% over the most recent 5 years available.
When did West Pharmaceutical Services net income hit its highest annual value?
- West Pharmaceutical Services net income reached its highest annual value of $661.80M in 2021.
What was West Pharmaceutical Services net income in 2024?
- West Pharmaceutical Services (WST) net income in 2024 was $492.70M.
What was West Pharmaceutical Services net income in 2025?
- West Pharmaceutical Services (WST) net income in 2025 was $493.70M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.